ROPIVACAINE, SODIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE clinical trials

A randomized, Phase 4, double-blind, placebo-controlled, 6-arm crossover study to investigate the systemic effect of lidocaine and ropivacaine when used for Transversus Abdominis Plane (TAP) blocks on hyperalgesia and pain perception in healthy volunteers aged 18 to 64 years.

This study looks at how well two common pain-numbing medicines, lidocaine and ropivacaine, work to reduce pain sensitivity. Healthy men aged 18 and over will take part. We want to understand their effects when used in a specific type of pain block.